DOMESCO Medical Import Export Joint Stock Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares DOMESCO Medical Import Export Joint Stock Corp with three other
companies in this sector in Vietnam:
Imexpharm Corp
(2018
sales of 1.18 trillion Dong [US$51.07 million]
of which 100%
was Medicine in Vietnam),
Hatay Pharmaceutical JSC
(1.71 trillion Dong [US$73.50 million]
), and
Mekophar Chemical Pharma JSC
(1.16 trillion Dong [US$49.88 million]
).
Sales Analysis.
DOMESCO Medical Import Export Joint Stock Corp reported sales of 1.39 trillion Dong (US$59.70 million)
for the
year ending
December of 2018.
This
represents
an
increase of 3.4%
versus 2017, when the company's sales were 1.34 trillion Dong.
This was the third consecutive year of growth at DOMESCO Medical Import Export Joint Stock Corp.
The sales level in 2018 was fairly close to the level five years ago: in 2013, DOMESCO Medical Import Export Joint Stock Corp had sales
of 1.43 trillion Dong.